bcl-2 expression in endometrial hyperplasia and carcinoma

被引:33
|
作者
Niemann, TH
Trgovac, TL
McGaughy, VR
Vaccarello, L
机构
[1] ARTHUR G JAMES CANC HOSP,COLUMBUS,OH 43210
[2] OHIO STATE UNIV,MED CTR,DIV GYNECOL ONCOL,COLUMBUS,OH 43210
关键词
D O I
10.1006/gyno.1996.0329
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The bcl-2 gene codes for a protein which functions to inhibit apoptotic cell death. bcl-2 overexpression was originally described in follicular lymphoma, but more recently bcl-2 expression has been observed in a variety of other human neoplasms. In this study we used immunohistochemistry to examine bcl-2 protein expression in endometrial hyperplasia and carcinoma. bcl-2 protein was observed in 4/4 cases of complex hyperplasia, 1/4 cases of complex atypical hyperplasia, and 10/29 cases of carcinoma. The staining observed in the cases of complex atypical hyperplasia and carcinoma was focal and less intense than the reactivity of normal proliferative endometrium. We conclude that bcl-2 protein is seldom overexpressed in complex atypical hyperplasia or carcinoma of the endometrium. Rather, in many cases of endometrial carcinoma bcl-2 expression appears to be decreased. (C) 1996 Academic Press, Inc.
引用
收藏
页码:318 / 322
页数:5
相关论文
共 50 条
  • [41] Apoptosis, bcl-2 expression, and proliferative activity in human endometrial stroma and endometrial granulated lymphocytes
    Jones, RK
    Searle, RF
    Stewart, JA
    Turner, S
    Bulmer, JN
    BIOLOGY OF REPRODUCTION, 1998, 58 (04) : 995 - 1002
  • [42] Down regulation of bcl-2 is a potential marker of the efficacy or progestin therapy in the treatment of endometrial hyperplasia
    Amezcua, CA
    Zheng, WX
    Felix, JC
    LABORATORY INVESTIGATION, 1999, 79 (01) : 112A - 112A
  • [43] Immunohistochemical Expression of BCL-2 in Endometrial Carcinoma and Its Comparison With Hormone Receptor Status and Epidermal Growth Factor
    Kandaswamy, Sharanya
    Palanisamy, Poongothai
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [44] Cellular apoptosis susceptibility gene expression in endometrial carcinoma:: Correlation with Bcl-2, Bax, and caspase-3 expression and outcome
    Peiró, G
    Diebold, J
    Baretton, GB
    Kimmig, R
    Löhrs, U
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2001, 20 (04) : 359 - 367
  • [45] Bcl-2 protein expression in atypical alveolar cell hyperplasia (AACH) of the lung
    Mori, M
    Rao, SK
    Woda, BA
    Baker, SP
    Fraire, AE
    MODERN PATHOLOGY, 1998, 11 (01) : 178A - 178A
  • [46] Expression of apoptosis and Bcl-2 family in gastric carcinoma.
    Shinohara, T
    Ohshima, K
    Kume, T
    Kikuchi, M
    Yoshitake, H
    Sakai, T
    Yamashita, Y
    Shirakusa, T
    GASTROENTEROLOGY, 1997, 112 (04) : A655 - A655
  • [47] Expression of bcl-2 protein in gastric carcinoma and its significance
    LIU Hai Feng
    World Journal of Gastroenterology, 1998, (03) : 48 - 50
  • [48] Bcl-2 expression and triple negative profile in breast carcinoma
    Kallel-Bayoudh, Imen
    Ben Hassen, Hanen
    Khabir, Abdelmajid
    Boujelbene, Noureddine
    Daoud, Jamel
    Frikha, Mounir
    Sallemi-Boudawara, Tahia
    Aifa, Sami
    Rebai, Ahmed
    MEDICAL ONCOLOGY, 2011, 28 : S55 - S61
  • [49] Prognostic impact of bcl-2 expression on advanced nasopharyngeal carcinoma
    Chen, Mu-Kuan
    Lai, Jui-Chung
    Chang, Cheng-Chuan
    Chang, Julia H.
    Chang, Yu-Jun
    Chen, Hui-Chuan
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2008, 30 (08): : 1052 - 1057
  • [50] Utility of PTEN, MLH1, ARID1A, Beta-catenin, Bax and BCL-2 biomarkers in endometrial hyperplasia and endometrioid endometrial carcinoma
    Dover, D. Kosemetin
    Senol, S.
    Aydin, A.
    VIRCHOWS ARCHIV, 2015, 467 : S155 - S155